Covidien’s Q4 Earnings Fall, but Still Beat View (COV)

Healthcare products maker Covidien plc (COV) on Friday said both its profit and revenue declined in its fiscal fourth quarter, although results were still enough to beat out analysts’ expectations.

The Dublin, Ireland-based company reported fiscal fourth quarter net income of $461 million, or 95 cents per share, compared with $451 million, or 92 cents per share, in the year-ago period. Excluding special items, adjusted profit was $1.02 per share.

Revenue fell 2.5% from last year to $3 billion.

On average, Wall Street analysts expected a smaller profit of $1.00 per share, on lower revenue of $2.98 billion.

Covidien shares rose 94 cents, or +1.8%, in premarket trading Friday. The stock has climbed about 18.5% since the beginning of 2012.

The Bottom Line
Shares of Covidien plc (COV) have a 1.95% dividend yield, based on last night’s closing stock price of $53.36. The stock has technical support in the $48-$51 price area. If the shares can firm up, we see overhead resistance around the $55-$57 price levels.

Covidien plc (COV) is not recommended at this time, holding a DARS™ Rating of 3.4 out of 5 stars.

Be sure to visit our complete recommended list of the Best Dividend Stocks, as well as a detailed explanation of our ratings system here.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here